Dynamics of lung defense in pneumonia: Resistance, resilience, and remodeling

Annual Review of Physiology

Volumn 77, Issue , 2015, Pages 407-430

  Quinton, Lee J ^a   Mizgerd, Joseph P ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Innate immunity; Lung; NF B; Respiratory infection; STAT3

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; STAT3 PROTEIN;

AGED; ARTICLE; BACTERIAL IMMUNITY; CELL SPECIFICITY; CELLS BY BODY ANATOMY; DISEASE RESISTANCE; GERIATRIC PATIENT; HUMAN; IMMUNITY; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; LIVER CELL; LUNG ALVEOLUS EPITHELIUM CELL; LUNG ALVEOLUS MACROPHAGE; LUNG INFECTION; LUNG INJURY; LUNG RESISTANCE; LYMPHOCYTE; NEUTROPHIL; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROPHYLAXIS; ADAPTIVE IMMUNITY; AIRWAY REMODELING; ANIMAL; DISEASE MODEL; IMMUNOLOGY; LUNG; PATHOPHYSIOLOGY; PHYSIOLOGY; RESPIRATORY TRACT MUCOSA;

ADAPTIVE IMMUNITY; AIRWAY REMODELING; ANIMALS; DISEASE MODELS, ANIMAL; DISEASE RESISTANCE; HUMANS; IMMUNITY, INNATE; LUNG; MACROPHAGES, ALVEOLAR; PNEUMONIA; RESPIRATORY MUCOSA;

EID: 84922780886     PISSN: 00664278     EISSN: 15451585     Source Type: Book Series    
DOI: 10.1146/annurev-physiol-021014-071937     Document Type: Article

References (155)

1. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, et al. 2012. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2163-96
2. Armstrong GL, Conn LA, Pinner RW. 1999. Trends in infectious disease mortality in the United States during the 20th century. JAMA 281:61-66
3. Liu L, Johnson HL, Cousens S, Perin J, Scott S, et al. 2012. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 379:2151-61
4. Mizgerd JP. 2012. Respiratory infection and the impact of pulmonary immunity on lung health and disease. Am. J. Respir. Crit. CareMed. 186:824-29
5. Curns AT, Holman RC, Sejvar JJ, Owings MF, Schonberger LB. 2005. Infectious disease hospitalizations among older adults in the United States from 1990 through 2002. Arch. Intern. Med. 165:2514-20
6. FryAM, ShayDK, Holman RC,Curns AT,AndersonLJ. 2005. Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002. JAMA 294:2712-19
7. Mizgerd JP. 2006. Lung infection-A public health priority. PLOS Med. 3:e76
8. Van Eeden S, Leipsic J, Paul Man SF, Sin DD. 2012. The relationship between lung inflammation and cardiovascular disease. Am. J. Respir. Crit. CareMed. 186:11-16
9. Edmond K, Scott S, Korczak V, Ward C, Sanderson C, et al. 2012. Long term sequelae from childhood pneumonia; systematic review and meta-Analysis. PLOS ONE 7:e31239
10. Shah FA, Pike F, Alvarez K, Angus D, Newman AB, et al. 2013. Bidirectional relationship between cognitive function and pneumonia. Am. J. Respir. Crit. CareMed. 188:586-92
11. Ayres JS, Schneider DS. 2012. Tolerance of infections. Annu. Rev. Immunol. 30:271-94
12. MedzhitovR, Schneider DS, SoaresMP. 2012. Disease tolerance as a defense strategy. Science 335:936-41
13. CillonizC, Ewig S, Polverino E,MarcosMA, EsquinasC, et al. 2011. Microbial aetiology of communityacquired pneumonia and its relation to severity. Thorax 66:340-46
14. Jones RN. 2010. Microbial etiologies of hospital-Acquired bacterial pneumonia and ventilator-Associated bacterial pneumonia. Clin. Infect. Dis. 51(Suppl. 1):81-87
15. Mizgerd JP, Skerrett SJ. 2008. Animal models of human pneumonia. Am. J. Physiol. Lung Cell. Mol. Physiol. 294:L387-98
16. Matute-Bello G, Frevert CW, Martin TR. 2008. Animal models of acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 295:L379-99
17. Mizgerd JP. 2008. Acute lower respiratory tract infection. N. Engl. J. Med. 358:716-27
18. Quinton LJ, Mizgerd JP. 2011. NF-κB and STAT3 signaling hubs for lung innate immunity. Cell Tissue Res. 343:153-65
19. Alcamo E, Mizgerd JP, Horwitz BH, Bronson R, Beg AA, et al. 2001. Targeted mutation of TNF receptor I rescues theRelA-deficient mouse and reveals a critical role forNF-κBin leukocyte recruitment. J. Immunol. 167:1592-600
20. Quinton LJ, Jones MR, Simms BT, Kogan MS, Robson BE, et al. 2007. Functions and regulation of NF-κB RelA during pneumococcal pneumonia. J. Immunol. 178:1896-903
21. Picard C, von Bernuth H, Ghandil P, Chrabieh M, Levy O, et al. 2010. Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency. Medicine 89:403-25
22. Pannicke U, Baumann B, Fuchs S, Henneke P, Rensing-Ehl A, et al. 2013. Deficiency of innate and acquired immunity caused by an IKBKB mutation. N. Engl. J. Med. 369:2504-14
23. Hussell T, Bell TJ. 2014. Alveolar macrophages: plasticity in a tissue-specific context. Nat. Rev. Immunol. 14:81-93
24. Pittet LA, Quinton LJ, Yamamoto K, Robson BE, Ferrari JD, et al. 2011. Earliest innate immune responses require macrophage RelA during pneumococcal pneumonia. Am. J. Respir. Cell Mol. Biol. 45:573-81
25. Quinton LJ, JonesMR, Robson BE,Mizgerd JP. 2009. Mechanisms of the hepatic acute-phase response during bacterial pneumonia. Infect. Immun. 77:2417-26
26. Hess C, Herr C, Beisswenger C, Zakharkina T, Schmid RM, Bals R. 2010. Myeloid RelA regulates pulmonary host defense networks. Eur. Respir. J. 35:343-52
27. Cakarova L, Marsh LM, Wilhelm J, Mayer K, Grimminger F, et al. 2009. Macrophage tumor necrosis factor-αinduces epithelial expression of granulocyte-macrophage colony-stimulating factor: impact on alveolar epithelial repair. Am. J. Respir. Crit. CareMed. 180:521-32
28. MarriottHM, Gascoyne KA,Gowda R, Geary I,Nicklin MJ, et al. 2011. IL-1βregulates CXCL8 release and influences disease outcome in response to Streptococcus pneumoniae, defining intracellular cooperation between pulmonary epithelial cells and macrophages. Infect. Immun. 80:1140-49
29. GuilliamsM, De Kleer I, Henri S, Post S, Vanhoutte L, et al. 2013. Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF. J. Exp. Med. 210:1977-92
30. Murphy J, Summer R, Wilson AA, Kotton DN, Fine A. 2008. The prolonged life-span of alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 38:380-85
31. Janssen WJ, Barthel L, Muldrow A, Oberley-Deegan RE, Kearns MT, et al. 2011. Fas determines differential fates of resident and recruited macrophages during resolution of acute lung injury. Am. J. Respir. Crit. Care Med. 184:547-60
32. Marriott HM, Bingle CD, Read RC, Braley KE, Kroemer G, et al. 2005. Dynamic changes in Mcl-1 expression regulate macrophage viability or commitment to apoptosis during bacterial clearance. J. Clin. Investig. 115:359-68
33. Aberdein JD, Cole J, Bewley MA,MarriottHM, DockrellDH.2013. Alveolar macrophages in pulmonary host defence\-The unrecognized role of apoptosis as a mechanism of intracellular bacterial killing. Clin. Exp. Immunol. 174:193-202
34. Steinwede K, Henken S, Bohling J,Maus R, Ueberberg B, et al. 2012. TNF-related apoptosis-inducing ligand (TRAIL) exerts therapeutic efficacy for the treatment of pneumococcal pneumonia in mice. J. Exp. Med. 209:1937-52
35. Cohen TS, Prince AS. 2013. Activation of inflammasome signaling mediates pathology of acute P . Aeruginosa pneumonia. J. Clin. Investig. 123:1630-37
36. Dela Cruz CS, Liu W, He CH, Jacoby A, Gornitzky A, et al. 2012. Chitinase 3-like-1 promotes Streptococcus pneumoniae killing and augments host tolerance to lung antibacterial responses. Cell Host Microbe 12:34-46
37. Weber M, Lambeck S, Ding N, Henken S, Kohl M, et al. 2012. Hepatic induction of cholesterol biosynthesis reflects a remote adaptive response to pneumococcal pneumonia. FASEB J. 26:2424-36
38. Alymova IV, Samarasinghe A, Vogel P, Green AM,Weinlich R, McCullers JA. 2014. A novel cytotoxic sequence contributes to influenza A viral protein PB1-F2 pathogenicity and predisposition to secondary bacterial infection. J. Virol. 88:503-15
39. Nakahira K, Choi AM. 2013. Autophagy: a potential therapeutic target in lung diseases. Am. J. Physiol. Lung Cell. Mol. Physiol. 305:L93-107
40. Byrne BG, Dubuisson JF, Joshi AD, Persson JJ, Swanson MS. 2013. Inflammasome components coordinate autophagy and pyroptosis as macrophage responses to infection. MBio 4:e00620-12
41. Yuan K, Huang C, Fox J, Laturnus D, Carlson E, et al. 2012. Autophagy plays an essential role in the clearance of Pseudomonas aeruginosa by alveolar macrophages. J. Cell Sci. 125:507-15
42. Tam JM, Mansour MK, KhanNS, Seward M, Puranam S, et al. 2014. Dectin-1-dependent LC3 recruitment to phagosomes enhances fungicidal activity in macrophages. J. Infect. Dis. 210:1844-54
43. KnowlesMR, Daniels LA, Davis SD, Zariwala MA, Leigh MW. 2013. Primary ciliary dyskinesia. Recent advances in diagnostics, genetics, and characterization of clinical disease. Am. J. Respir. Crit. CareMed. 188:913-22
44. RoyMG, Livraghi-Butrico A, Fletcher AA, McElwee MM, Evans SE, et al. 2014. Muc5b is required for airway defence. Nature 505:412-16
45. Wright JR. 2005. Immunoregulatory functions of surfactant proteins. Nat. Rev. Immunol. 5:58-68
46. Mijares LA, Wangdi T, Sokol C, Homer R, Medzhitov R, Kazmierczak BI. 2011. Airway epithelial MyD88 restores control of Pseudomonas aeruginosa murine infection via an IL-1-dependent pathway. J. Immunol. 186:7080-88
47. Moser C, Weiner DJ, Lysenko E, Bals R, Weiser JN, Wilson JM. 2002. β-Defensin 1 contributes to pulmonary innate immunity in mice. Infect. Immun. 70:3068-72
48. Yamamoto K, Ahyi AN, Pepper-Cunningham ZA, Ferrari JD, Wilson AA, et al. 2014. Roles of lung epithelium in neutrophil recruitment during pneumococcal pneumonia. Am. J. Respir. Cell Mol. Biol. 50:253-62
49. Yamamoto K, Ferrari JD, Cao Y, Ramirez MI, Jones MR, et al. 2012. Type I alveolar epithelial cells mount innate immune responses during pneumococcal pneumonia. J. Immunol. 189:2450-59
50. Starner TD, Barker CK, JiaHP, Kang Y, McCray PB Jr. 2003. CCL20 is an inducible product of human airway epithelia with innate immune properties. Am. J. Respir. Cell Mol. Biol. 29:627-33
51. Kovach MA, Ballinger MN, Newstead MW, Zeng X, Bhan U, et al. 2012. Cathelicidin-related antimicrobial peptide is required for effective lung mucosal immunity in Gram-negative bacterial pneumonia. J. Immunol. 189:304-11
52. Markart P,Korfhagen TR,Weaver TE, AkinbiHT. 2004. Mouse lysozymeMis important in pulmonary host defense against Klebsiella pneumoniae infection. Am. J. Respir. Crit. CareMed. 169:454-58
53. Chan YR, Liu JS, Pociask DA, ZhengM,Mietzner TA, et al. 2009. Lipocalin 2 is required for pulmonary host defense against Klebsiella infection. J. Immunol. 182:4947-56
54. Warszawska JM, Gawish R, Sharif O, Sigel S, Doninger B, et al. 2013. Lipocalin 2 deactivates macrophages and worsens pneumococcal pneumonia outcomes. J. Clin. Investig. 123:3363-72
55. Choi SM,McAleer JP, Zheng M, Pociask DA, Kaplan MH, et al. 2013. Innate Stat3-mediated induction of the antimicrobial protein Reg3γis required for host defense against MRSA pneumonia. J. Exp. Med. 210:551-61
56. Liu Y, Bartlett JA, Di ME, Bomberger JM, Chan YR, et al. 2013. SPLUNC1/BPIFA1 contributes to pulmonary host defense against Klebsiella pneumoniae respiratory infection. Am. J. Pathol. 182:1519-31
57. Liu Y, DiME, ChuHW, Liu X,Wang L, et al. 2013. Increased susceptibility to pulmonary Pseudomonas infection in Splunc1 knockout mice. J. Immunol. 191:4259-68
58. Fischer AJ, Lennemann NJ, Krishnamurthy S, Pocza P, Durairaj L, et al. 2011. Enhancement of respiratory mucosal antiviral defenses by the oxidation of iodide. Am. J. Respir. Cell Mol. Biol. 45:874-81
59. Moskwa P, Lorentzen D, Excoffon KJ, Zabner J,McCray PB Jr, et al. 2007. A novel host defense system of airways is defective in cystic fibrosis. Am. J. Respir. Crit. Care Med. 175:174-83
60. Evans SE, Xu Y, TuvimMJ, Dickey BF. 2010. Inducible innate resistance of lung epithelium to infection. Annu. Rev. Physiol. 72:413-35
61. Cleaver JO, YouD,MichaudDR, Pruneda FA, Juarez MM, et al. 2014. Lung epithelial cells are essential effectors of inducible resistance to pneumonia. Mucosal Immunol. 7:78-88
62. Mei J, Liu Y, Dai N, Favara M, Greene T, et al. 2010. CXCL5 regulates chemokine scavenging and pulmonary host defense to bacterial infection. Immunity 33:106-17
63. Bozinovski S, Jones J, Beavitt SJ, Cook AD, Hamilton JA, Anderson GP. 2004. Innate immune responses to LPS inmouse lung are suppressed and reversed by neutralization ofGM-CSF via repression of TLR-4. Am. J. Physiol. Lung Cell. Mol. Physiol. 286:L877-85
64. Unkel B, Hoegner K, Clausen BE, Lewe-Schlosser P, Bodner J, et al. 2012. Alveolar epithelial cells orchestrate DC function in murine viral pneumonia. J. Clin. Investig. 122:3652-64
65. Kallal LE, Schaller MA, Lindell DM, Lira SA, Lukacs NW. 2010. CCL20/CCR6 blockade enhances immunity to RSV by impairing recruitment of DC. Eur. J. Immunol. 40:1042-52
66. Phadke AP, Akangire G, Park SJ, Lira SA, Mehrad B. 2007. The role of CC chemokine receptor 6 in host defense in a model of invasive pulmonary aspergillosis. Am. J. Respir. Crit. Care Med. 175:1165-72
67. Matsuzaki Y, Xu Y, Ikegami M, Besnard V, Park KS, et al. 2006. Stat3 is required for cytoprotection of the respiratory epithelium during adenoviral infection. J. Immunol. 177:527-37
68. Quinton LJ, Jones MR, Robson BE, Simms BT, Whitsett JA, Mizgerd JP. 2008. Alveolar epithelial STAT3, IL-6 family cytokines, and host defense during Escherichia coli pneumonia. Am. J. Respir. Cell Mol. Biol. 38:699-706
69. Laan M, Prause O, Miyamoto M, Sjostrand M, Hytonen AM, et al. 2003. A role of GM-CSF in the accumulation of neutrophils in the airways caused by IL-17 and TNF-α. Eur. Respir. J. 21:387-93
70. Shui JW, Larange A, Kim G, Vela JL, Zahner S, et al. 2012. HVEM signalling at mucosal barriers provides host defence against pathogenic bacteria. Nature 488:222-25
71. Jaillon S, Galdiero MR, Del Prete D, Cassatella MA, Garlanda C, Mantovani A. 2013. Neutrophils in innate and adaptive immunity. Semin. Immunopathol. 35:377-94
72. Brandes M, Klauschen F, Kuchen S, Germain RN. 2013. A systems analysis identifies a feedforward inflammatory circuit leading to lethal influenza infection. Cell 154:197-212
73. Ichikawa A, Kuba K, Morita M, Chida S, Tezuka H, et al. 2013. CXCL10-CXCR3 enhances the development of neutrophil-mediated fulminant lung injury of viral and nonviral origin. Am. J. Respir. Crit. Care Med. 187:65-77
74. Yamada M, Gomez JC, Chugh PE, Lowell CA, Dinauer MC, et al. 2011. Interferon-γ production by neutrophils during bacterial pneumonia in mice. Am. J. Respir. Crit. CareMed. 183:1391-401
75. Puga I, Cols M, Barra CM, He B, Cassis L, et al. 2012. B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen. Nat. Immunol. 13:170-80
76. Tillett WS, Francis T. 1930. Serological reactions in pneumonia with non-protein somatic fraction of pneumococcus. J. Exp. Med. 52:561-71
77. Gabay C, Kushner I. 1999. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 340:448-54
78. Ahyi AN, Quinton LJ, Jones MR, Ferrari JD, Pepper-Cunningham ZA, et al. 2013. Roles of STAT3 in protein secretion pathways during the acute-phase response. Infect. Immun. 81:1644-53
79. Quinton LJ, Blahna MT, Jones MR, Allen E, Ferrari JD, et al. 2012. Hepatocyte-specific mutation of bothNF-κB RelA and STAT3 abrogates the acute phase response in mice. J. Clin. Investig. 122:1758-63
80. Mizgerd JP, SpiekerMR, Doerschuk CM. 2001. Early response cytokines and innate immunity: essential roles for TNF receptor 1 and type I IL-1 receptor during Escherichia coli pneumonia in mice. J. Immunol. 166:4042-48
81. Lu J, Marnell LL, Marjon KD, Mold C, Du Clos TW, Sun PD. 2008. Structural recognition and functional activation of FcγR by innate pentraxins. Nature 456:989-92
82. Yuste J, Botto M, Bottoms SE, Brown JS. 2007. Serum amyloid P aids complement-mediated immunity to Streptococcus pneumoniae. PLOS Pathog. 3:1208-19
83. Matthay MA, Zemans RL. 2011. The acute respiratory distress syndrome: pathogenesis and treatment. Annu. Rev. Pathol. 6:147-63
84. Freeman AF, Holland SM. 2009. Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes. Pediatr. Res. 65:R32-37
85. Freeman AF, Kleiner DE, Nadiminti H, Davis J, Quezado M, et al. 2007. Causes of death in hyper-IgE syndrome. J. Allergy Clin. Immunol. 119:1234-40
86. Milner JD, Brenchley JM, Laurence A, Freeman AF, Hill BJ, et al. 2008. Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452:773-76
87. Saito M, Nagasawa M, Takada H, Hara T, Tsuchiya S, et al. 2011. Defective IL-10 signaling in hyper-IgE syndrome results in impaired generation of tolerogenic dendritic cells and induced regulatory T cells. J. Exp. Med. 208:235-49
88. Hokuto I, Ikegami M, Yoshida M, Takeda K, Akira S, et al. 2004. Stat-3 is required for pulmonary homeostasis during hyperoxia. J. Clin. Investig. 113:28-37
89. Ikegami M, Falcone A, Whitsett JA. 2008. STAT-3 regulates surfactant phospholipid homeostasis in normal lung and during endotoxin-mediated lung injury. J. Appl. Physiol. 104:1753-60
90. Kida H, MucenskiML,Thitoff AR,LeCrasTD, Park KS, et al. 2008. GP130-STAT3 regulates epithelial cell migration and is required for repair of the bronchiolar epithelium. Am. J. Pathol. 172:1542-54
91. Lian X, Qin Y, Hossain SA, Yang L, White A, et al. 2005. Overexpression of Stat3C in pulmonary epithelium protects against hyperoxic lung injury. J. Immunol. 174:7250-56
92. Li Y, Du H, Qin Y, Roberts J, Cummings OW, Yan C. 2007. Activation of the signal transducers and activators of the transcription 3 pathway in alveolar epithelial cells induces inflammation and adenocarcinomas in mouse lung. Cancer Res. 67:8494-503
93. Jones MR, Quinton LJ, Simms BT, Lupa MM, Kogan MS, Mizgerd JP. 2006. Roles of interleukin-6 in activation of STAT proteins and recruitment of neutrophils during Escherichia coli pneumonia. J. Infect. Dis. 193:360-69
94. Heymann D, L'Her E, Nguyen J-M, Raher S, Canfrere I, et al. 1996. Leukaemia inhibitory factor (LIF) production in pleural effusions: comparisonwith production of IL-4, IL-8, IL-10 and macrophage-colony stimulating factor (M-CSF). Cytokine 8:410-16
95. Jorens PG, De Jongh R, Bossaert LL, De Backer W, Herman AG, et al. 1996. High levels of leukaemia inhibitory factor in ARDS. Cytokine 8:873-76
96. Dagoneau N, Scheffer D, Huber C, Al-Gazali LI, Di Rocco M, et al. 2004. Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann/Schwartz-Jampel type 2 syndrome. Am. J. Hum. Genet. 74:298-305
97. Quinton LJ, Mizgerd JP, Hilliard KL, Jones MR, Kwon CY, Allen E. 2012. Leukemia inhibitory factor signaling is required for lung protection during pneumonia. J. Immunol. 188:6300-8
98. Bhattacharya J, Matthay MA. 2013. Regulation and repair of the alveolar-capillary barrier in acute lung injury. Annu. Rev. Physiol. 75:593-615
99. Aujla SJ, Chan YR, Zheng M, FeiM, Askew DJ, et al. 2008. IL-22mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat. Med. 14:275-81
100. Kumar P, ThakarMS, Ouyang W, Malarkannan S. 2013. IL-22 from conventional NK cells is epithelial regenerative and inflammation protective during influenza infection. Mucosal Immunol. 6:69-82
101. Pociask DA, Scheller EV, Mandalapu S,McHugh KJ, Enelow RI, et al. 2013. IL-22 is essential for lung epithelial repair following influenza infection. Am. J. Pathol. 182:1286-96
102. Zemans RL, Briones N, Campbell M, McClendon J, Young SK, et al. 2011. Neutrophil transmigration triggers repair of the lung epithelium via β-catenin signaling. Proc. Natl. Acad. Sci. USA 108:15990-95
103. Liu Y, Sadikot RT, Adami GR,Kalinichenko VV, Pendyala S, et al. 2011. FoxM1mediates the progenitor function of type II epithelial cells in repairing alveolar injury induced by Pseudomonas aeruginosa. J. Exp. Med. 208:1473-84
104. Kumar PA, Hu Y, Yamamoto Y, Hoe NB, Wei TS, et al. 2011. Distal airway stem cells yield alveoli in vitro and during lung regeneration following H1N1 influenza infection. Cell 147:525-38
105. Kotton DN. 2012. Next-generation regeneration: the hope and hype of lung stem cell research. Am. J. Respir. Crit. Care Med. 185:1255-60
106. Korfhagen TR, Kitzmiller J, Chen G, Sridharan A, Haitchi HM, et al. 2012. SAM-pointed domain ETS factor mediates epithelial cell-intrinsic innate immune signaling during airway mucous metaplasia. Proc. Natl. Acad. Sci. USA 109:16630-35
107. Chen G, Korfhagen TR, Karp CL, Impey S, Xu Y, et al. 2014. Foxa3 induces goblet cell metaplasia and inhibits innate antiviral immunity. Am. J. Respir. Crit. CareMed. 189:301-13
108. Kim KC. 2012. Role of epithelial mucins during airway infection. Pulm. Pharmacol. Ther. 25:415-19
109. Choi S, Park YS, Koga T, Treloar A, Kim KC. 2011. TNF-α is a key regulator of MUC1, an antiinflammatory molecule, during airway Pseudomonas aeruginosa infection. Am. J. Respir. Cell Mol. Biol. 44:255-60
110. ShanM,Gentile M, Yeiser JR,Walland AC, Bornstein VU, et al. 2013. Mucus enhances gut homeostasis and oral tolerance by delivering immunoregulatory signals. Science 342:447-53
111. Aggarwal NR, King LS, D'Alessio FR. 2014. Diverse macrophage populations mediate acute lung inflammation and resolution. Am. J. Physiol. Lung Cell. Mol. Physiol. 306:L709-25
112. Johnston LK, Rims CR, Gill SE, McGuire JK, Manicone AM. 2012. Pulmonary macrophage subpopulations in the induction and resolution of acute lung injury. Am. J. Respir. Cell Mol. Biol. 47:417-26
113. Wang J, Li F, Sun R, Gao X, Wei H, et al. 2013. Bacterial colonization dampens influenza-mediated acute lung injury via induction of M2 alveolar macrophages. Nat. Commun. 4:2106
114. Westphalen K, Gusarova GA, Islam MN, Subramanian M, Cohen TS, et al. 2014. Sessile alveolar macrophages communicate with alveolar epithelium to modulate immunity. Nature 506:503-6
115. Huynh ML, Fadok VA, Henson PM. 2002. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-β1 secretion and the resolution of inflammation. J. Clin. Investig. 109:41-50
116. Levy BD, Serhan CN. 2014. Resolution of acute inflammation in the lung. Annu. Rev. Physiol. 76:467-92
117. Deng JC, Cheng G, Newstead MW, Zeng X, Kobayashi K, et al. 2006. Sepsis-induced suppression of lung innate immunity is mediated by IRAK-M. J. Clin. Investig. 116:2532-42
118. D'Alessio FR, Tsushima K, Aggarwal NR, West EE, Willett MH, et al. 2009. CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. J. Clin. Investig. 119:2898-913
119. Braciale TJ, Sun J, KimTS. 2012. Regulating the adaptive immune response to respiratory virus infection. Nat. Rev. Immunol. 12:295-305
120. Xu X, Weiss ID, Zhang HH, Singh SP, Wynn TA, et al. 2014. Conventional NK cells can produce IL-22 and promote host defense in Klebsiella pneumoniae pneumonia. J. Immunol. 192:1778-86
121. Monticelli LA, Sonnenberg GF, Abt MC, Alenghat T, Ziegler CGK, et al. 2011. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat. Immunol. 12:1045-54
122. Jamieson AM, Pasman L, Yu S, Gamradt P, Homer RJ, et al. 2013. Role of tissue protection in lethal respiratory viral-bacterial coinfection. Science 340:1230-34
123. Geisler F, Algul H, Paxian S, Schmid RM. 2007. Genetic inactivation of RelAp65 sensitizes adult mouse hepatocytes to TNF-induced apoptosis in vivo and in vitro. Gastroenterology 132:2489-503
124. Sander LE, Sackett SD, Dierssen U, Beraza N, Linke RP, et al. 2010. Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J. Exp. Med. 207:1453-64
125. Poe SL, Arora M, Oriss TB, Yarlagadda M, Isse K, et al. 2013. STAT1-regulated lung MDSC-like cells produce IL-10 and efferocytose apoptotic neutrophils with relevance in resolution of bacterial pneumonia. Mucosal Immunol. 6:189-99
126. Herold S, Tabar TS, Janssen H, Hoegner K, Cabanski M, et al. 2011. Exudate macrophages attenuate lung injury by the release of IL-1 receptor antagonist in gram-negative pneumonia. Am. J. Respir. Crit. Care Med. 183:1380-90
127. Aggarwal NR, Tsushima K, Eto Y, Tripathi A, Mandke P, et al. 2014. Immunological priming requires regulatory T cells and IL-10-producing macrophages to accelerate resolution from severe lung inflammation. J. Immunol. 92:4453-64
128. Gupta N, Krasnodembskaya A, Kapetanaki M, Mouded M, Tan X, et al. 2012. Mesenchymal stem cells enhance survival and bacterial clearance in murine Escherichia coli pneumonia. Thorax 67:533-39
129. Lee JW, Fang X, Gupta N, Serikov V, Matthay MA. 2009. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc. Natl. Acad. Sci. USA 106:16357-62
130. Sridhar S, Begom S, Bermingham A, Hoschler K, AdamsonW, et al. 2013. Cellular immune correlates of protection against symptomatic pandemic influenza. Nat. Med. 19:1305-12
131. WilkinsonTM, Li CK, Chui CS,Huang AK, Perkins M, et al. 2012. Preexisting influenza-specificCD4+ T cells correlate with disease protection against influenza challenge in humans. Nat. Med. 18:274-80
132. Strutt TM,McKinstry KK, Marshall NB, Vong AM, Dutton RW, Swain SL. 2013. Multipronged CD4+ T-cell effector and memory responses cooperate to provide potent immunity against respiratory virus. Immunol. Rev. 255:149-64
133. Malley R, Anderson PW. 2012. Serotype-independent pneumococcal experimental vaccines that induce cellular as well as humoral immunity. Proc. Natl. Acad. Sci. USA 109:3623-27
134. Chen K, McAleer JP, Lin Y, Paterson DL, Zheng M, et al. 2011. Th17 cells mediate clade-specific, serotype-independent mucosal immunity. Immunity 35:997-1009
135. Malley R, Trzcinski K, Srivastava A, Thompson CM, Anderson PW, Lipsitch M. 2005. CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization. Proc. Natl. Acad. Sci. USA 102:4848-53
136. Cohen JM, Khandavilli S, Camberlein E, Hyams C, Baxendale HE, Brown JS. 2011. Protective contributions against invasive Streptococcus pneumoniae pneumonia of antibody and Th17-cell responses to nasopharyngeal colonisation. PLOS ONE 6:e25558
137. Lundgren A, Bhuiyan TR, Novak D, Kaim J, Reske A, et al. 2012. Characterization of Th17 responses to Streptococcus pneumoniae in humans: comparisons between adults and children in a developed and a developing country. Vaccine 30:3897-907
138. Wright AK, Bangert M, Gritzfeld JF, Ferreira DM, Jambo KC, et al. 2013. Experimental human pneumococcal carriage augments IL-17A-dependent T-cell defence of the lung. PLOS Pathog. 9:e1003274
139. Giefing C, Meinke AL, Hanner M, Henics T, Bui MD, et al. 2008. Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies. J. Exp. Med. 205:117-31
140. Purwar R, Campbell J, Murphy G, Richards WG, Clark RA, Kupper TS. 2011. Resident memory T cells (T(RM)) are abundant in human lung: diversity, function, and antigen specificity. PLOS ONE 6:e16245
141. Sathaliyawala T, KubotaM, Yudanin N, Turner D, Camp P, et al. 2013. Distribution and compartmentalization of human circulating and tissue-resident memory T cell subsets. Immunity 38:187-97
142. Teijaro JR, Turner D, Pham Q, Wherry EJ, Lefrançois L, Farber DL. 2011. Cutting edge: Tissueretentive lungmemoryCD4Tcells mediate optimal protection to respiratory virus infection. J. Immunol. 187:5510-14
143. Wakim LM, Gupta N, Mintern JD, Villadangos JA. 2013. Enhanced survival of lung tissue-resident memory CD8+ T cells during infection with influenza virus due to selective expression of IFITM3. Nat. Immunol. 14:238-45
144. Paget C, Trottein F. 2013. Role of type 1 natural killer T cells in pulmonary immunity. Mucosal Immunol. 6:1054-67
145. Gold MC, Lewinsohn DM. 2013. Co-dependents: MR1-restricted MAIT cells and their antimicrobial function. Nat. Rev. Microbiol. 11:14-19
146. Nakasone C, Yamamoto N, Nakamatsu M, Kinjo T, Miyagi K, et al. 2007. Accumulation of γ/δ T cells in the lungs and their roles in neutrophil-mediated host defense against pneumococcal infection. Microbes Infect. 9:251-58
147. Randall TD,Mebius RE. 2014. The development and function of mucosal lymphoid tissues: a balancing act with micro-organisms. Mucosal Immunol. 7(3):455-66
148. Krone CL, van de Groep K, Trzcinski K, Sanders EA, Bogaert D. 2014. Immunosenescence and pneumococcal disease: an imbalance in host-pathogen interactions. Lancet Respir. Med. 2:141-53
149. Vijg J, Suh Y. 2013. Genome instability and aging. Annu. Rev. Physiol. 75:645-68
150. Tevy MF, Giebultowicz J, Pincus Z, Mazzoccoli G, Vinciguerra M. 2013. Aging signaling pathways and circadian clock-dependent metabolic derangements. Trends Endocrinol. Metab. 24:229-37
151. Campisi J. 2013. Aging, cellular senescence, and cancer. Annu. Rev. Physiol. 75:685-705
152. Lalley PM. 2013. The aging respiratory system-pulmonary structure, function and neural control. Respir. Physiol. Neurobiol. 187:199-210
153. Faner R, Rojas M, Macnee W, Agusti A. 2012. Abnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. Am. J. Respir. Crit. CareMed. 186:306-13
154. Fedson DS. 2013. Treating influenza with statins and other immunomodulatory agents. Antivir. Res. 99:417-35
155. Griffin MR, Zhu Y, Moore MR, Whitney CG, Grijalva CG. 2013. US hospitalizations for pneumonia after a decade of pneumococcal vaccination. N. Engl. J. Med. 369:155-63